| |
| |
|
| Insider
Information: |
Mccarthy Sean A. |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
634,249 |
|
|
Indirect Shares
|
93,158 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
727,407 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytomx Therapeutics, Inc. |
CTMX |
|
2024-03-26 |
634,249 |
2024-03-26 |
93,158 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
77 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEOOfficer |
• • – |
2015-10-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
158,737 |
|
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2016-11-30 |
4 |
A |
$9.10 |
$17,999 |
D/D |
1,979 |
1,979 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-03-20 |
4 |
AS |
$19.60 |
$281,123 |
D/D |
(14,343) |
1,979 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-03-20 |
4 |
OE |
$0.95 |
$13,554 |
D/D |
14,343 |
16,322 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-04-03 |
4 |
AS |
$16.94 |
$80,990 |
D/D |
(4,781) |
1,979 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-04-03 |
4 |
OE |
$0.95 |
$4,518 |
D/D |
4,781 |
6,760 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-04-04 |
4 |
AS |
$17.50 |
$83,668 |
D/D |
(4,781) |
1,979 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-04-04 |
4 |
OE |
$0.95 |
$4,518 |
D/D |
4,781 |
6,760 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-05-01 |
4 |
OE |
$0.95 |
$4,518 |
D/D |
4,781 |
6,760 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-05-01 |
4 |
AS |
$15.70 |
$75,062 |
D/D |
(4,781) |
1,979 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-05-31 |
4 |
A |
$8.68 |
$19,665 |
D/D |
2,266 |
4,245 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-06-05 |
4 |
AS |
$15.00 |
$4,500 |
D/D |
(300) |
4,245 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-06-05 |
4 |
OE |
$0.95 |
$284 |
D/D |
300 |
4,545 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-06-26 |
4 |
S |
$15.00 |
$67,215 |
D/D |
(4,481) |
4,245 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-06-26 |
4 |
OE |
$0.95 |
$4,235 |
D/D |
4,481 |
8,726 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-07-03 |
4 |
AS |
$15.52 |
$74,201 |
D/D |
(4,781) |
4,245 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-07-03 |
4 |
OE |
$0.95 |
$4,518 |
D/D |
4,781 |
9,026 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-08-09 |
4 |
AS |
$15.00 |
$71,715 |
D/D |
(4,781) |
4,245 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-08-09 |
4 |
OE |
$0.95 |
$4,518 |
D/D |
4,781 |
9,026 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-08-31 |
4 |
OE |
$0.95 |
$17,724 |
D/D |
18,756 |
23,001 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-08-31 |
4 |
AS |
$17.50 |
$328,260 |
D/D |
(18,756) |
4,245 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-09-01 |
4 |
AS |
$17.32 |
$171,988 |
D/D |
(9,930) |
4,245 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-09-01 |
4 |
OE |
$0.95 |
$9,384 |
D/D |
9,930 |
14,175 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-10-02 |
4 |
AS |
$18.57 |
$177,566 |
D/D |
(9,562) |
4,245 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
President and CEO |
• • – |
2017-10-02 |
4 |
OE |
$0.95 |
$9,036 |
D/D |
9,562 |
13,807 |
0 |
- |
|
77 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
